Marijuana Company of America, Inc. Share Price

Equities

MCOA

US56782E2046

Pharmaceuticals

Market Closed - OTC Markets 01:12:55 03/05/2024 am IST 5-day change 1st Jan Change
0.0001 USD -50.00% Intraday chart for Marijuana Company of America, Inc. -50.00% +9,900.00%
Sales 2020 281K 23.39M Sales 2021 1.03M 85.88M Capitalization 8.55M 712M
Net income 2020 -12M -1B Net income 2021 -10M -834M EV / Sales 2020 50.5 x
Net Debt 2020 1.2M 99.75M Net Debt 2021 3.69M 307M EV / Sales 2021 11.9 x
P/E ratio 2020
-0.33 x
P/E ratio 2021
-0.62 x
Employees 7
Yield 2020 *
-
Yield 2021
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Marijuana Company of America, Inc. Accepts the Resignation of Director Edward Manolos from Board of Directors CI
Marijuana Company of America, Inc. Announces Resignation of Tad Mailander as Independent Director CI
Marijuana Company of America, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Marijuana Company of America, Inc. Signs Master Agreement with Mitra-9 Suite of Alcohol Alternative Beverages Derived from the Natural Herbs Kava and Kratom CI
Marijuana Company of America, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Marijuana Company of America Inc. Appoints Marco Guerrero to New Role as hempSMART Advisor Guerrero to Guide South American Distribution of hempSMART (TM) Products CI
Marijuana Company of America, Inc. Announces Resignation of Marco Guerrero from the Board of Directors CI
Marijuana Company of America, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Marijuana Company of America, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Marijuana Company of America, Inc. Auditor Raises 'Going Concern' Doubt CI
Marijuana Company of America, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Marijuana Company of America, Inc. announced that it has received $2.880982 million in funding from St. George Investments, LLC CI
Marijuana Company of America, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Marijuana Company of America, Inc. completed the acquisition of cDistro, LLC for $2.8 million. CI
Marijuana Company of America, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
More news
1 day-50.00%
1 week-50.00%
1 month-50.00%
3 months-50.00%
More quotes
1 week
0.00
Extreme 0.0001
0.00
1 month
0.00
Extreme 0.0001
0.00
Current year
0.00
Extreme 0
0.00
1 year
0.00
Extreme 0
0.00
3 years
0.00
Extreme 0
0.01
5 years
0.00
Extreme 0
0.97
10 years
0.00
Extreme 0
11.91
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 31/18/31
Sales & Marketing - -
Members of the board TitleAgeSince
Chief Executive Officer 62 31/18/31
Director/Board Member 51 12/20/12
More insiders
Date Price Change Volume
02/24/02 0.0001 -50.00% 22,809,641
01/24/01 0.0002 +33.33% 92,458,002
30/24/30 0.00015 +50.00% 64,879,849
29/24/29 0.0001 0.00% 7,515,564
26/24/26 0.0001 0.00% 25,613,347

Delayed Quote OTC Markets, May 03, 2024 at 01:12 am IST

More quotes
Marijuana Company of America, Inc. is an owner and operator of licensed cannabis cultivation, processing, and dispensary facilities. The Company is a developer, producer, and distributor of branded cannabis and cannabidiol (CBD) products in the United States. Through its wholly owned subsidiary cDistro, Inc., it offers CBD brands along with smoke and vape shop-related products to wholesalers, c-stores, specialty retailers, and consumers in North America. Through its wholly owned subsidiary HSmart, Inc., it develops and sells CBD products under the brand name hempSMART. Its hempSMART wellness products offerings include hempSMART Brain, hempSMART Pain, hempSMART Pain Cream, hempSMART Drops, hempSMART Pet Drops, hempSMART Face, and hempSMART Drink Mix. hempSMART Brain is a personal care consumer product encapsulated with enriched non-psychoactive industrial hemp derived CBD. hempSMART Pain Cream each container is formulated with 300mg of non-psychoactive CBD.
More about the company